Effect of Infraclavicular and Interscalen Block on Oxygenitaon of the Forearm

Upper Extremity Fracture Clinical Trial

Official title:

Effect of Infraclavicular and Interscalen Block on Oxygenitaon of the Forearm : Randomized Controlled Study.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04748211
• Other study ID #: 2017-116-06/12
• Status: Completed
• Phase: N/A
• Start date: June 15, 2018
• Est. completion date: June 15, 2019

Study information

• Verified date: February 2021
• Source: Bulent Ecevit University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

to research the oxygenitaon effects of infraclavicular and interscalene blocks on the forearm.

Description:

To research the oxygenation effects of infraclavicular and interscalen blocks on the forearm by comparing the blood flow (BF) values using the USG, Perfusion index (PI) and Near infrared spectroscopy (NIRS) values using the massimo device.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 104
• Est. completion date: June 15, 2019
• Est. primary completion date: June 15, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• aged between 18-65

• ASA Score I-III

• undergoing elective or emergency arm, elbow and forearm surgery

Exclusion Criteria:

• Patient's refusal for Brachial Plexus Blockage

• Patients who had any neurological disorders preventing the evaluation of the sensory block in the upper extremity,

• Infection in the area to be blocked with ICB or ISB,

• Non-cooperated patients

• Patients with coagulopathy,

• Morbidly obese patients

• Patients with diabetes mellitus

• Patients with hypertension

• Patients with peripheral artery disease

• Patients with allergy to the drugsto be used

• Patients who had trauma in the area scheduled for the block

• Paitens who had deterioration of anatomical integrity because of previous surgery

• Pregnant women

• Patients whose block failed

Related Conditions & MeSH terms

• Upper Extremity Fracture

Intervention

Procedure:
• Infraclavicular Block
USI and neurostimulator guided infraclavicular block, 10 ml 2% lidocain and 10 ml 0.05% marcaine was administered for local anetshesia. After the block was administered MAP, HR, TAV, BAD, BAA, BF, PI and rSO 2 values were measured and recorded at the 10th, 20th, and 30th minutes.
• Interscalen Block
USI and neurostimulator guided interscalen block, 10 ml 2% lidocain and 10 ml 0.05% marcaine was administered for local anetshesia. After the block was administered MAP, HR, TAV, BAD, BAA, BF, PI and rSO 2 values were measured and recorded at the 10th, 20th, and 30th minutes.

Locations

Country	Name	City	State
Turkey	Zonguldak Bulent Ecevit University	Zonguldak

Sponsors (1)

Lead Sponsor	Collaborator
Bulent Ecevit University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	oxygenation of the forearm	to compare the oxygenation of the forearm by measuring perfusion index device	during the procedure three times